BioAge Labs, Inc. (BIOA)
NASDAQ: BIOA · Real-Time Price · USD
17.29
+0.24 (1.41%)
At close: May 29, 2026, 4:00 PM EDT
17.68
+0.39 (2.26%)
After-hours: May 29, 2026, 7:16 PM EDT
BioAge Labs Revenue
BioAge Labs had revenue of $2.77M in the quarter ending March 31, 2026, with 91.04% growth. This brings the company's revenue in the last twelve months to $10.32M, up 610.96% year-over-year. In the year 2025, BioAge Labs had annual revenue of $9.00M.
Revenue (ttm)
$10.32M
Revenue Growth
+610.96%
P/S Ratio
74.50
Revenue / Employee
$166,387
Employees
62
Market Cap
768.59M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 9.00M | - | - |
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionBIOA News
- 3 days ago - BioAge Labs initiated with a Buy at Roth Capital - TheFly
- 7 days ago - BioAge Labs to Present at Upcoming Investor Conferences - GlobeNewsWire
- 17 days ago - BioAge Labs initiated with a Buy at BTIG - TheFly
- 21 days ago - BioAge Labs R&D Day: BGE-102 Phase I Shows Big hs-CRP Drops, Sets Up Cardio & DME POC Trials - MarketBeat
- 21 days ago - BioAge Labs Transcript: R&D Day 2026 - Transcripts
- 21 days ago - BioAge Labs Slides: FY 2026 - Filings
- 21 days ago - BioAge Labs reports Q1 EPS (52c), consensus (63c) - TheFly
- 21 days ago - BioAge Labs Reports First Quarter 2026 Financial Results and Provides Business Updates - GlobeNewsWire